Ethic Inc. Harvard Bioscience Inc Transaction History
Ethic Inc.
- $5.89 Billion
- Q3 2025
A detailed history of Ethic Inc. transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Ethic Inc. holds 12,439 shares of HBIO stock, worth $4,975. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,439
Previous 13,009
4.38%
Holding current value
$4,975
Previous $5,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding HBIO
# of Institutions
75Shares Held
22.5MCall Options Held
101KPut Options Held
22K-
Amh Equity LTD3.51MShares$1.4 Million2.13% of portfolio
-
Black Rock Inc. New York, NY2.84MShares$1.14 Million0.0% of portfolio
-
Harvey Partners, LLC Tarrytown, NY2.14MShares$856,4390.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.85MShares$741,5560.0% of portfolio
-
Granahan Investment Management, LLC Waltham, MA1.5MShares$600,6030.03% of portfolio
About HARVARD BIOSCIENCE INC
- Ticker HBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 41,636,500
- Market Cap $16.7M
- Description
- Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...